AC-OLE-01-VA
Sponsors
Cerecin
Conditions
Alzheimer Disease
Phase 1
A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects
CompletedNCT05408780
Start: 2022-07-14End: 2022-10-24Updated: 2023-10-17
AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions
CompletedNCT05628636
Start: 2022-11-14End: 2023-04-03Updated: 2023-10-18